IRAE
Clinical trials for IRAE explained in plain language.
Never miss a new study
Get alerted when new IRAE trials appear
Sign up with your email to follow new studies for IRAE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Common nausea pill may tame immunotherapy's harsh side effects in liver cancer
Symptom relief Recruiting nowThis study tests whether ondansetron, a drug typically used for nausea, can lower the risk and severity of side effects from immunotherapy in people with liver cancer. About 134 patients will receive ondansetron alongside their standard cancer treatment. The goal is to see if thi…
Matched conditions: IRAE
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
New study aims to predict severe side effects in cancer immunotherapy
Knowledge-focused Recruiting nowThis study follows 200 adults with advanced cancer who are receiving immunotherapy. Researchers will track their physical and emotional distress, financial burden, care needs, and quality of life over one year. The goal is to develop a tool that can predict which patients are at …
Matched conditions: IRAE
Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC